Eltrekibart clinical trials
Also written LY3041658.
- studies test it
- 7
- open now
- 0
- in phase 3
- 0
- first study started
- 2014
How each study uses eltrekibart is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- Not in FDA's approval records
- European Union
- Not in EMA's list of EU-wide authorisations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
Studies by the year they started
7 studies that test it; most in 2020 (2)
| Year | Studies |
|---|---|
| 2014 | 1 |
| 2016 | 1 |
| 2020 | 2 |
| 2023 | 1 |
| 2024 | 1 |
| 2026 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 7 · Other 0
Studies
Open first, then newest update. How each study uses eltrekibart is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 7
- A Study of Eltrekibart and Mirikizumab in Adult Patients With Moderately to Severely Active Ulcerative ColitisActive, not recruitingPhase 2Eli Lilly and CompanyNCT06598943Written as Eltrekibart
- A Study of Eltrekibart (LY3041658) in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT07545590Written as LY3041658
- A Study of Eltrekibart (LY3041658) in Adult Participants With Moderate to Severe Hidradenitis SuppurativaCompletedPhase 2Eli Lilly and CompanyNCT06046729Written as Eltrekibart
- A Study of LY3041658 in Adults With Hidradenitis SuppurativaCompletedPhase 2Eli Lilly and CompanyNCT04493502Written as LY3041658
- A Study of LY3041658 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT04653168Written as LY3041658
- A Study of LY3041658 in Participants With Skin DiseasesCompletedPhase 1Eli Lilly and CompanyNCT02896868Written as LY3041658
- Safety Study of LY3041658 in Healthy ParticipantsCompletedPhase 1Eli Lilly and CompanyNCT02148627Written as LY3041658 (SC)
Codes
What other systems call eltrekibart · ClinicalTrials.gg INT018340
- UNII (FDA) WB62WIH13EELTREKIBARTOne source FDA
- NCI Thesaurus C199036EltrekibartOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| UNII (FDA) | WB62WIH13E | ELTREKIBART | One source FDA |
| NCI Thesaurus | C199036 | Eltrekibart | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.